Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular genetic screening after non-ischaemic sudden cardiac arrest and no overt cardiomyopathy in real life: A major tool for the aetiological diagnostic work-up.

Archives of cardiovascular diseases - 1 Jan 2000

Weizman Orianne, Gandjbakhch Estelle, Magnin-Poull Isabelle, Proukhnitzky Julie, Bordet Céline, Palmyre Aurélien, Bloch Adrien, Fressart Véronique, Charron Philippe

Abstract excerpt

BACKGROUND: With the development of advanced sequencing techniques, genetic testing has emerged as a valuable tool for the work-up of non-ischaemic sudden cardiac arrest (SCA). AIMS: To evaluate the effectiveness of genetic testing in patients with unexplained SCA, according to clinical phenotype. METHODS: All patients who underwent molecular genetic testing for non-ischaemic SCA with no left ventricular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Death, Sudden, Cardiac
Share to France

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Testing

Share to Hospitals, University

Share to NAV1.5 Voltage-Gated Sodium Channel

Share to Predictive Value of Tests

Share to Ryanodine Receptor Calcium Release Channel

Source

Identifiers

PMID: 38670870
DOI: 10.1016/j.acvd.2024.02.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular genetic screening after non-ischaemic sudden cardiac arrest and no overt cardiomyopathy in real life: A major tool for the aetiological diagnostic work-up.PMID 38670870Read ↗

Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry).Semantic proximity Read ↗

Sudden death and cardiac arrest without phenotype: the utility of genetic testing.Semantic proximity Read ↗

Importance of genetic testing in unexplained cardiac arrestSemantic proximity Read ↗

Genetic Causes of Sudden Cardiac Arrest in the CommunitySemantic proximity Read ↗

The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic TherapiesSemantic proximity Read ↗

Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.Semantic proximity Read ↗

Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?Semantic proximity Read ↗

Targeted next generation sequencing in a young population with suspected inherited malignant cardiac arrhythmias.Semantic proximity Read ↗

Prevalence and electrophysiological phenotype of rare SCN5A genetic variants identified in unexplained sudden cardiac arrest survivors.Semantic proximity Read ↗

Sudden Cardiac Death and Channelopathies: What Lies behind the Clinical Significance of Rare Splice-Site Alterations in the Genes Involved?Semantic proximity Read ↗

From Death to Life/Back to the Future: Detailed Premorbid Clinical and Family History Can Save Lives and Address the Final Diagnosis in Sudden Unexplained Deaths With Negative Autopsy.Semantic proximity Read ↗

Assessment of genetic causes of cardiac arrest.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.